Jens Gammeltoft Gerwien - Cell Cybernetics Laboratory, State University Hospital of Copenhagen

基本信息

浏览量：38

职业迁徙

个人简介

暂无内容

研究兴趣

论文共 68 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选

AB0456 BARICITINIB AS MONOTHERAPY FOR TREATMENT OF RHEUMATOID ARTHRITIS: SUMMARY OF DATA FROM FIVE REAL-WORLD DATA SOURCES

C. J. Edwards,A. Finckh, T. Takeuchi,A. Kleyer,E. Haladyj,C. Laedermann,J. Gerwien,T. Treuer,L. Zaremba-Pechmann,J. S. Smolen

ANNALS OF THE RHEUMATIC DISEASES (2023): 1419-1419

引用0浏览0引用

Efficacité Et Arrêts De Traitement Sous Baricitinib Dans La Polyarthrite Rhumatoïde Selon L’âge Du Patient Et Le Traitement Antérieur: Données Sur 2 Ans Issues De La Cohorte Européenne De L’étude RA-BE-REAL

R. Alten,G.R. Burmester,C.J. Edwards,E.G. Favalli,I. De La Torre, K.J. Ng,E. Haladyj,J.G. Gerwien,L. Zaremba-Pechmann,B. Fautrel,J.H. Salmon

Revue du Rhumatisme (2023): A117-A118

引用0浏览0引用

Comparative Effectiveness, Time to Discontinuation, and Patient-Reported Outcomes with Baricitinib in Rheumatoid Arthritis: 2-Year Data from the Multinational, Prospective Observational RA-BE-REAL Study in European Patients

Rieke Alten,Gerd R. Burmester,Marco Matucci-Cerinic,Jean-Hugues Salmon,Andrew Östör,Khai Jing Ng,Jens Gerwien,Liliana Zaremba-Pechmann,Alan J. M. Brnabic,Bruno Fautrel

RHEUMATOLOGY AND THERAPY（2023）

引用5浏览0WOS引用

Time to Discontinuation and Effectiveness with Baricitinib in Rheumatoid Arthritis: 12-Month European Data from a Multinational, Prospective, Observational Study

R. Alten,G. Burmester,M. Matucci-Cerinic,A. Ostor,L. Zaremba-Pechmann,T. Treuer, K. Ng,J. Gerwien, K. Gibson,B. Fautrel

Rheumatologyno. Supplement_2 (2023)

引用1浏览0引用

P127 Baricitinib Efficacy in Moderate Rheumatoid Arthritis - A Post-hoc Analysis from Two Phase III Trials

Bruce W. Kirkham,Elena Nikiphorou,Christopher J. Edwards,Mohamed Sheesh,Ewa Haladyj,Jens Gerwien,Liliana Zaremba-Pechmann,Peter C. Taylor

RHEUMATOLOGY（2023）

引用0浏览0引用

Effectiveness of Biologics, Patient-Reported Outcomes, and Clinical Photography in a Subset of Patients with Moderate-to-Severe Psoriasis: Week 12 Results from the Psoriasis Study of Health Outcomes (Psoho)

Massimo Travaglini,Julia -Tatjana Maul, Christian Kors,Shirin Zaheri,Jens Gerwien, Michaela Mueller,Alan Brnabic,Silvia Sabatino,Christopher Schuster,Tsen-Fang Tsai

CLINICAL COSMETIC AND INVESTIGATIONAL DERMATOLOGY (2023): 2971-2983

引用1浏览0WOS引用

Systematic Literature Review of Real-World Evidence on Baricitinib for the Treatment of Rheumatoid Arthritis

Blanca Hernández-Cruz,Uta Kiltz,Jérôme Avouac,Tamas Treuer,Ewa Haladyj,Jens Gerwien,Chandreyee Dutta Gupta,Fabrizio Conti

Rheumatology and therapy（2023）

引用5浏览0WOS引用

Efficacité Du Baricitinib Dans La Polyarthrite Rhumatoïde Modérée : Analyse Post-Hoc De Deux Essais De Phase III

B. Kirkham,E. Nikiphorou,C.J. Edwards, M. Sheesh,E. Haladyj,J.G. Gerwien,L. Zaremba-Pechmann,P.C. Taylor,B. Fautrel

Revue du Rhumatisme (2023): A118

引用0浏览0引用

DISCONTINUATION AND EFFECTIVENESS OF BARICITINIB IN RHEUMATOID ARTHRITIS ACCORDING TO PATIENT AGE AND PRIOR TREATMENT: 2-YEAR DATA FROM THE EUROPEAN COHORT OF THE RA-BEREAL STUDY

R. Alten,G. R. Burmester,C. J. Edwards,E. G. Favalli,I. De La Torre, K. Ng,E. Haladyj,J. Gerwien,L. Zaremba-Pechmann,B. Fautrel

ANNALS OF THE RHEUMATIC DISEASES (2023): 724-725

引用0浏览0引用

POS0848 DISCONTINUATION AND EFFECTIVENESS OF BARICITINIB IN RHEUMATOID ARTHRITIS ACCORDING TO PATIENT AGE AND PRIOR TREATMENT: 2-YEAR DATA FROM THE EUROPEAN COHORT OF THE RA-BE-REAL STUDY

R. Alten,G. R. Burmester,C. J. Edwards,E. G. Favalli,I. De La Torre, K. Ng,E. Haladyj,J. Gerwien,L. Zaremba-Pechmann,B. Fautrel

Scientific Abstracts (2023)

引用0浏览0引用

加载更多

作者统计

合作学者

合作机构

D-Core

合作者
学生
导师

暂无相似学者，你可以通过学者研究领域进行搜索筛选

数据免责声明

页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果，我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问，可以通过电子邮件方式联系我们：report@aminer.cn